Trial
NCT04602494
Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents
Phase IVTERMINATEDREGULATORYConfidence: MEDIUM
Sponsor
Massachusetts General Hospital
Collaborators
National Institute on Drug Abuse (NIDA)
Condition
Vaping
Intervention
Varenicline
Why stopped
The pilot study used apo-varenicline under temp FDA authorization. When varenicline was available an IND exemption was granted to enroll children, IRB approved a trial of varenicline in participants ages 16-25 June 27, 2022, the pilot was terminated
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-04-04